These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15591552)

  • 1. Health insurance company offers genetic screening to its clients.
    Tuffs A
    BMJ; 2004 Dec; 329(7479):1364. PubMed ID: 15591552
    [No Abstract]   [Full Text] [Related]  

  • 2. Insurance agreement to facilitate genetic testing.
    Delatycki M; Allen K; Williamson R
    Lancet; 2002 Apr; 359(9315):1433. PubMed ID: 11978360
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.
    Rogowski WH
    Med Decis Making; 2009; 29(2):224-38. PubMed ID: 19182214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic discrimination and screening for hemochromatosis.
    Alper JS; Geller LN; Barash CI; Billings PR; Laden V; Natowicz MR
    J Public Health Policy; 1994; 15(3):345-58. PubMed ID: 7983195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic screening for iron overload: No evidence of discrimination at 1 year.
    Hall MA; Barton JC; Adams PC; McLaren CE; Reiss JA; Castro O; Ruggiero A; Acton RT; Power TE; Bent TC
    J Fam Pract; 2007 Oct; 56(10):829-34. PubMed ID: 17908514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Paterson J; Toolis F
    Gut; 2001 Mar; 48(3):441-2. PubMed ID: 11256365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Using value of information analysis in decision making about applied research. The case of genetic screening for hemochromatosis in Germany].
    Rogowski WH; Grosse SD; Meyer E; John J; Palmer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):700-9. PubMed ID: 22526859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health risks, heredity screening and insurance].
    Arnold IJ; van de Vathorst S
    Ned Tijdschr Geneeskd; 1991 Mar; 135(11):480-3. PubMed ID: 2023656
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic screening and the insurance industry.
    Pokorski R
    Yale J Biol Med; 1991; 64(1):53-7. PubMed ID: 1897262
    [No Abstract]   [Full Text] [Related]  

  • 10. Health insurance problems are not going away.
    Swartz K
    Inquiry; 2000; 37(3):231-3. PubMed ID: 11111281
    [No Abstract]   [Full Text] [Related]  

  • 11. Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage.
    Shaheen NJ; Lawrence LB; Bacon BR; Barton JC; Barton NH; Galanko J; Martin CF; Burnett CK; Sandler RS
    Am J Gastroenterol; 2003 May; 98(5):1175-80. PubMed ID: 12809845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hemochromatosis.
    Billings PR; Barash C; Geller LN; Alper JS
    N Engl J Med; 1993 Dec; 329(27):2037; author reply 2037-8. PubMed ID: 8247088
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of the proposal for population based screening for hereditary hemochromatosis in Massachusetts.
    LeGraw JM
    J Biolaw Bus; 2001; 4(4):51-8. PubMed ID: 12751496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The context of genetic screening.
    Billings PR
    Yale J Biol Med; 1991; 64(1):47-52. PubMed ID: 1897261
    [No Abstract]   [Full Text] [Related]  

  • 15. How will improved forecasts of individual lifetimes affect underwriting?
    MacDonald AS
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1067-75. PubMed ID: 9304673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. As genetic tests move into the mainstream, challenges await for doctors and patients.
    Zielinski SL
    J Natl Cancer Inst; 2005 Mar; 97(5):334-6. PubMed ID: 15741567
    [No Abstract]   [Full Text] [Related]  

  • 17. British insurers continue with genetic tests.
    Dickson D
    Nat Med; 1999 Sep; 5(9):974. PubMed ID: 10471266
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutuality and solidarity: assessing risks and sharing losses.
    Wilkie D
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1039-44. PubMed ID: 9304668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [For the first time a health insurance company publishes drug data. Surprise: the thriftiest colleagues are in the East].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):53. PubMed ID: 11732399
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics and the moral mission of health insurance.
    Murray TH
    Hastings Cent Rep; 1992; 22(6):12-7. PubMed ID: 1428841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.